Author:
Steven C.Rogers
AlbertoCohen-Abbo
Description
- Results in most cases from infection with the Epstein-Barr virus (EBV) (a herpesvirus):
- Non-EBV causes of infectious mononucleosis (IM):
- Cytomegalovirus (CMV)
- Adenovirus
- Hepatitis A
- Herpesvirus 6
- HIV
- Rubella
- Toxoplasma gondii
- Group A β-hemolytic streptococci
- >90% of adults on serologic testing demonstrate prior infection with EBV:
- Most do not recollect specific IM symptoms
- Mode of transmission is close or intimate contact particularly with saliva from shedders who may or may not be symptomatic:
- Nickname kissing disease
- Viral shedding in saliva can persist intermittently for life
- May occur after transfusions/transplants
- Incubation period: 4-6 wk
- Immunologic response:
- T-cells response:
- T-cell response is responsible for an elevated absolute lymphocyte count and the associated clinical symptoms and complications
- Subtype of the T-cell lineage, cytotoxic CD8 cells (Downey cells), contain eccentrically placed and lobulated nuclei with vacuolated cytoplasm: The atypical lymphocytes seen on differential
- B-cell response:
- EBV infects and replicates in B-cells
- B-cells are then transformed into plasmacytoid cells that secrete immunoglobulins
- IgM antibody secreted: The heterophile antibody which is reactive against red cell antigens
- Mortality from IM is rare, but may occur due to the following complications:
- Airway edema
- Neurologic complications
- Secondary bacterial infection
- Splenic rupture
- Hepatic failure
- Myocarditis
- EBV infection has also been strongly linked to African Burkitt lymphoma and nasopharyngeal carcinoma
Pediatric Considerations |
- In children <4 yr, infection with EBV is often asymptomatic
- In children who do become symptomatic, there is propensity toward atypical presentations:
- Neutropenia, pneumonia, and varied rashes
- Mesenteric lymphadenopathy and splenomegaly can cause the illness to present with abdominal pain and be confused with appendicitis
- Infants and toddlers can present with only irritability and failure to thrive so must be considered when no other source can be identified
|
Signs and Symptoms
History
- Typically, an insidious onset over several days to weeks but may be abrupt onset
- Prodromal fatigue, malaise, arthralgias, and myalgias with a biphasic or waxing and waning course
- Prominent or worst ever sore throat and fever. Airway edema may be reported as difficulty breathing or respiratory distress
- Swollen lymph nodes
- Headache
- Significant abdominal pain is uncommon but when present should raise concern about marked splenic enlargement or splenic rupture
- Varied rashes can be seen in 18-34% of children and adolescents (not associated with antibiotics)
- Administration of ampicillin or amoxicillin in patients with IM is associated with development of a rash
Physical Exam
- Malaise and /or fatigue (90-100%)
- Pharyngitis (65-85%) and tonsillar enlargement
- Fever (80-95%)
- Eyelid edema (15-35%)
- Symmetric tender lymphadenopathy (100%)
- Hepatomegaly (15-25%)
- Splenomegaly (50-60%)
- Nonspecific rashes
- Morbilliform rash can be seen if the patient has been given ampicillin or amoxicillin:
- Typically develops 5-9 d after the onset of antibiotic therapy (should not be interpreted as a penicillin allergy)
- Petechia can occur on the skin or at the junction between the hard and the soft palate
- Complications found on exam:
- Airway compromise due to edema (1-5%)
- Severe abdominal tenderness may be due to splenic rupture (may also cause referred pain to left shoulder)
- Jaundice (∼5%) due to hepatitis or hepatic failure
- Hepatitis is the most common complication
- Neurologic findings consistent with:
- Encephalitis or cerebellitis
- Aseptic meningitis
- Guillain-Barre syndrome
- Optic neuritis
- Bell palsy
- Anemia (palor): May be due to hemolytic anemia, thrombocytopenia, agranulocytosis, hemophagocytic lymphohistiocytosis (HLH)
- Orchitis
- Neck tenderness and /or limited range of motion due to pain: Secondary bacterial such as jugular vein thrombosis (Lemierre syndrome due to Fusobacterium necrophorum), soft tissue infection such as retropharyngeal or peritonsillar abscesses
- Signs of shock: May be due to dehydration or a secondary anaerobic sepsis
Diagnostic Tests & Interpretation
Lab
- WBC with differential:
- Typically, a modest elevation in total WBC between 10,000-20,000, which peaks during week 2 of the illness; occasionally can be 30,000-50,000. A rare occurrence is the development of severe agranulocytosis, associated with recurrence or persistence of fever, and redevelopment of cervical adenopathy approximately 1 mo after onset of disease
- Lymphocyte countfindings suggestive of IM:
- >50% lymphocytes on differential
- Absolute lymphocyte count >4,500
- Elevated lymphocyte count with >10% atypical lymphocytes (up to 90% of patients)
- Liver function tests:
- Elevated with transaminases up to 3 times normal found in 80-85% of patients in the 1st 2 wk
- Significant elevations in bilirubin to the point of causing clinical jaundice in ∼5% of cases
- Monospot test detects presence of heterophile antibodies (which are not specific for EBV):
- Moderately sensitive (85%) and highly specific (practically 100%)
- Rarely false positives can occur with CMV, leukemia, lymphoma, rubella, hepatitis, HIV, or lupus
- Most patients develop heterophile antibodies after ∼1 wk of illness
- Small percentage of patients (<10%) never develop heterophile antibodies
- Heterophile antibodies peak at 2-5 wk and may persist for several months
- Positive test relates to a titer >1:40
- Results likely to be negative in children <4 yo
- Testing does exist for EBV-specific antibodies but is expensive, time consuming, and rarely needed
- Useful in patients with atypical/severe cases or when monospot testing is negative and confirmation of IM is desired
- Acute infection is indicated by antibodies (IgG, IgM) against viral capsid antigens (VCAs) without antibodies against the Epstein-Barr nuclear antigen (EBNA) which are only present during the latency period 3-4 wk after onset of illness
- Past infection indicated by negative IgM and positive EBNA
Imaging
Sonography or CT scan of abdomen for significant abdominal pain to identify splenic rupture and to ensure no signs of appendicitis
Differential Diagnosis
Divided into infectious and noninfectious causes:
- Infectious:
- Adenovirus
- CMV
- Streptococcal pharyngitis
- HIV
- Rubella
- Hepatitis A, B, C
- Diphtheria in nonimmunized populations
- Mumps
- Toxoplasmosis
- Noninfectious:
- Leukemia
- Lymphoma
- Medication-induced syndromephenytoin, sulfa drugs
Prehospital
ALERT |
- Follow stand ard universal precautions
- ABCs. Assess airway patency
- Initiate IV hydration with normal saline if patient is dehydrated
|
Initial Stabilization/Therapy
- ABC management. Airway edema may require intervention
- If possible, avoid placing patient in the same general area as posttransplant and other immunocompromised patients
ED Treatment/Procedures
- Supportive therapy:
- Hydration with IV or PO fluids
- Antipyretics for fever control
- Analgesics for pain of sore throat
- Steroids (methylprednisolone, prednisone, or dexamethasone) if there is significant pharyngeal/tonsillar edema with concern about impending airway obstruction. May also be considered for massive splenomegaly, myocarditis, hemolytic anemia, or HLH. Treatment is controversial and theoretically may be associated with increased risk of secondary infections or malignant disease
- Antiviral therapy has not been proven to effect clinical course but emerging research may suggest potential benefits of Valganciclovir.
- Antibiotics if concerned for bacterial superinfection:
- Avoid ampicillin and amoxicillin because of associated rash
- Counsel patient on athletic activity limitations (see follow-up recommendations)
Medication
- Methylprednisolone: 125 mg IV (peds: 2 mg/kg IV up to adult dose)
- Prednisone: 20-40 mg PO daily for 7 d (peds: 1 mg/kg up to adult dose) with subsequent tapering
- Dexamethasone: 12-16 mg PO (peds: 0.3 mg/kg up to adult dose)
Disposition
Admission Criteria
- Significant airway edema that represents any level of potential airway compromise
- Neurologic or severe hematologic/hepatic complications
- Inability to take PO
- Pain control
Discharge Criteria
- No airway compromise
- Mild hematologic complications or mild hepatitis
- Ability to take PO fluids
- Fever usually resolved within 10 d and lymph nodes and spleen within 4 wk; fatigue may continue for several weeks, although it may go on for 2-3 mo
Issues for Referral
- Infectious disease consultation may be useful if serology is not conclusive
- Significant complications or persistent symptoms
Follow-up Recommendations
- Contact sports, physical education, heavy lifting or other strenuous activity should be avoided in the 1st 8 wk regardless of spleen size or current symptoms
- After the initial 8-wk period patients need repeat outpatient evaluation to determine if they are able to return to full activity. Those with concerns of persistent symptoms including splenomegaly may require further studies (i.e., ultrasound) to determine when they are safe to return to full activity
ICD9
075 Infectious mononucleosis
ICD10
B27.00 Gammaherpesviral mononucleosis without complication
B27.10 Cytomegaloviral mononucleosis without complications
B27.90 Infectious mononucleosis, unspecified without complication
B27.80 Other infectious mononucleosis without complication
B27.09 Gammaherpesviral mononucleosis with other complications
B27.19 Cytomegaloviral mononucleosis with other complication
B27.89 Other infectious mononucleosis with other complication
B27.99 Infectious mononucleosis, unsp with other complication
SNOMED
271558008 Infectious mononucleosis (disorder)
186668002 Gammaherpesviral mononucleosis (disorder)
16196000 Cytomegaloviral mononucleosis (disorder)